Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$40.82 - $57.75 $416,364 - $589,050
10,200 New
10,200 $446,000
Q2 2022

Aug 15, 2022

SELL
$34.86 - $63.77 $20,916 - $38,262
-600 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$44.33 - $57.82 $84,227 - $109,858
-1,900 Reduced 76.0%
600 $35,000
Q4 2021

Feb 14, 2022

BUY
$40.27 - $56.99 $100,675 - $142,475
2,500 New
2,500 $111,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.